AKT1 and polycystic ovary syndrome: Additionally, a substantial difference in gene expression was noted between the BL treatment group and the model group, suggesting that BL may exert anti-PCOS effects by modulating the PI3K-Akt pathway, the TLR signaling system, and the IR route.